638 results on '"Owens, Charles"'
Search Results
2. The forgotten battles
3. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
4. Tunable thermal transport in 4D printed mechanical metamaterials
5. A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors.
6. Examining the relationship between rural residents' satisfaction with local hospital's COVID‐19 response and intention to use the hospital.
7. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
8. Examining the relationship between rural residents’ satisfaction with local hospital's COVID‐19 response and intention to use the hospital
9. Metastatic cells are preferentially vulnerable to lysosomal inhibition
10. Technological advances increase stress on the battlefield
11. Supplementary Table 1 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
12. Supplementary Figure and Table Legends from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
13. Data from Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors
14. Supplementary Figure 1 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
15. Supplementary Figure 3 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
16. Supplementary Table 2 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
17. Supplemental Figure 2 from Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors
18. Supplementary Figure 2 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
19. Supplemental Figure 1 from Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors
20. Supplemental figure legends from Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors
21. The impact of interpersonal support, supervisory support, and employee engagement on employee turnover intentions: Differences between financially distressed and highly financially distressed hospitals
22. Supplemental materials and methods from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
23. Supplemental Table from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
24. Supp Figure 4 from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
25. Supplemental Figure Legends from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
26. Data from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
27. Supplementary Figures S1-7 from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
28. Supp Figure 2 from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
29. Supplementary Tables from Androgen Receptor Regulates CD44 Expression in Bladder Cancer
30. Data from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
31. Supplementary Information from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
32. Supplemental Table 4 from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
33. Supp Figure 3 from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
34. Supp Figure 5 from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
35. Supplementary Figure 5 from Androgen Receptor Regulates CD44 Expression in Bladder Cancer
36. Supplementary Figure Legends from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
37. Supplemental Figures 1-5 from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
38. Supplementary Figure S1 from Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
39. Supplementary Figure 6 from Androgen Receptor Regulates CD44 Expression in Bladder Cancer
40. Supplemental Table 5 from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
41. Supplemental Table 3 from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
42. Supplemental Table 2 from Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis
43. Supp Figure 1 from Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis
44. Supplementary Methods, Tables 1 - 9 from Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
45. Data from Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer
46. Data from A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers
47. Supplementary Figure Legends 1-6 from Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer
48. Supplementary Figures 1-6 from Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer
49. Supplementary Figure 1 from A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers
50. Supplementary Table 1 from A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.